Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I

Autor: Alice Janssen, Lambertus P. van den Heuvel, Maïlys Guillard, Eva Morava, Nina Ondruskova, Hana Hansikova, Jiri Zeman, Machiko Kadoya, Isao Yuasa, Katerina Vesela, Ron A. Wevers, Yoshinao Wada, Dirk J. Lefeber
Rok vydání: 2011
Předmět:
Male
congenital
hereditary
and neonatal diseases and abnormalities

Glycosylation
Genomic disorders and inherited multi-system disorders Energy and redox metabolism [IGMD 3]
Peptide
Neuroinformatics [DCN 3]
CDG - an update
medicine.disease_cause
Renal disorder Energy and redox metabolism [IGMD 9]
Models
Biological

Genomic disorders and inherited multi-system disorders [IGMD 3]
chemistry.chemical_compound
Congenital Disorders of Glycosylation
Catalytic Domain
Genetics
medicine
Humans
Genetics(clinical)
Child
Genetics (clinical)
chemistry.chemical_classification
Mutation
biology
Isoelectric focusing
Transferrin
Mitochondrial medicine Energy and redox metabolism [IGMD 8]
Glycostation disorders [IGMD 4]
Molecular biology
Human genetics
Renal disorder Membrane transport and intracellular motility [IGMD 9]
Isoelectric point
chemistry
Biochemistry
Spectrometry
Mass
Matrix-Assisted Laser Desorption-Ionization

biology.protein
Isoelectric Focusing
Perception and Action Glycostation disorders [DCN 1]
Protein Processing
Post-Translational

Neuraminidase
Zdroj: Journal of Inherited Metabolic Disease
Journal of Inherited Metabolic Disease, 34, 4, pp. 901-6
Journal of Inherited Metabolic Disease, 34, 901-6
ISSN: 1573-2665
0141-8955
DOI: 10.1007/s10545-011-9311-y
Popis: Item does not contain fulltext Congenital disorders of glycosylation (CDG) form a group of metabolic disorders caused by deficient glycosylation of proteins and/or lipids. Isoelectric focusing (IEF) of serum transferrin is the most common screening method to detect abnormalities of protein N-glycosylation. On the basis of the IEF profile, patients can be grouped into CDG type I or CDG type II. Several protein variants of transferrin are known that result in a shift in isoelectric point (pI). In some cases, these protein variants co-migrate with transferrin glycoforms, which complicates interpretation. In two patients with abnormal serum transferrin IEF profiles, neuraminidase digestion and subsequent IEF showed profiles suggestive of the diagnosis of CDG type I. Mass spectrometry of tryptic peptides of immunopurified transferrin, however, revealed a novel mutation at the N-glycan attachment site. In case 1, a peptide with mutation p.Asn630Thr in the 2nd glycosylation site was identified, resulting in an additional band at disialotransferrin position on IEF. After neuraminidase digestion, a single band was found at the asialotransferrin position, indistinguishable from CDG type I patients. In case 2, a peptide with mutation p.Asn432His was found. These results show the use of mass spectrometry of transferrin peptides in the diagnostic track of CDG type I.
Databáze: OpenAIRE